塞马格卢提德的眼部不良事件:系统性审查和元分析
Gabriella R Natividade1,2,3, Bernardo F Spiazzi2,4, Matheus W Baumgarten3
1Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
JAMA ophthalmology
|August 14, 2025
概括
用于治疗糖尿病和肥胖症的塞马格卢提德不增加眼睛疾病或糖尿病视网膜病变的风险. 然而,与非动脉炎前部缺血性视神经病变 (NAION) 的潜在联系需要进一步调查.
科学领域:
- 内分泌学和新陈代谢学
- 眼科医生 眼科 眼科
- 临床药理学 临床药理学
背景情况:
- 赛马格卢提德是一种GLP-1受体激动剂,广泛用于2型糖尿病和肥胖症.
- 虽然它对心血管有好处,但它对眼睛健康的影响,特别是关于不良事件的影响,仍然不清楚.
- 了解这些风险对于患者安全和明智的治疗决策至关重要.
研究的目的:
- 为了评估治疗塞马格卢提德的患者眼部不良事件,糖尿病视网膜病变和非动脉炎前部缺血性视神经病变 (NAION) 的发生率.
- 综合随机临床试验的证据,以评估关于眼睛健康的塞马格卢提德的安全性.
- 确定当前数据是否足够,以得出关于塞马格卢提德眼部安全性的最终结论.
主要方法:
- 在主要数据库 (PubMed,Embase,Cochrane) 进行了系统的文献搜索,寻找相关的随机临床试验.
- 数据的提取和合成涉及描述性分析,使用随机效应和固定效应模型的元分析,偏差风险评估 (RoB 2.0) 和证据质量评估 (GRADE).
- 使用试验顺序分析 (TSA) 来评估样本大小是否足以得出可靠的结论.
主要成果:
- 对73,640名参与者进行的78项试验的分析表明,塞马格卢提德与眼睛疾病 (OR, 1.01) 或糖尿病视网膜病变 (OR, 1.04) 的风险增加无关.
- 研究人员观察到,塞马格卢提德治疗与非动脉炎前部缺血性视神经病变 (NAION) 的几率增加之间存在统计学上显著的关联 (OR, 3.92).
- 对于糖尿病视网膜病变的结论,TSA表示样本大小足够,但对于NAION却没有,这表明对这种特定不良事件的证据有限.
结论:
- 塞马格卢提德治疗似乎不会增加一般眼睛疾病或糖尿病视网膜病变的风险.
- 观察到与NAION的关联值得谨慎,但由于样本大小的限制,目前的证据不足以做出最终结论.
- 建议进行进一步的大规模研究,以彻底调查半黄和NAION之间的潜在联系.
相关概念视频
01:27Open Angle Glaucoma: Treatment
568
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
568
01:25Glaucoma: Overview
755
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
755
01:28Angle Closure Glaucoma: Treatment
681
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
681
01:19Pharmacovigilance
993
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
993